butabarbital decreases outcomes of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Coadministration of CYP3A4 inducers may possibly lower sufentanil stages and efficacy, probably precipitating withdrawal syndrome in people who may have developed Bodily dependence to sufentanil. Discontinuati